Stent Implant Articles & Analysis
29 news found
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
Confluent’s engineered solutions to the most challenging design problems enable our OEM medical device customers to offer life-saving implantable products. Our customers rely on Confluent for materials science and associated manufacturing expertise which is critical to the function and value of their most demanding, high growth products – proprietary expertise which ...
MOTIV is a drug-eluting bioresorbable peripheral vascular scaffold made from REVA’s proprietary Tyrocore polymer that is designed to dissolve over time, leaving the artery free of a permanent implant and thereby allowing the artery to return to its natural movement or “vasomotion.” Due to their temporary nature, bioresorbable stents are commonly ...
This complementary alliance will support iSTAR Medical’s development and commercial efforts for MINIject®, as well as provide an opportunity to expand AbbVie’s eye care business, building on its glaucoma portfolio which includes drops, sustained release implants, and stent offerings. MINIject® received Conformité Européenne ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
ArterioSorb is an innovative medical implant product currently being developed by Arterius, a UK medical device micro/SME, to treat coronary artery disease (CAD). ...
gammaCore is contraindicated for patients if they: Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck Are using another device at the same ...
As previously published, IVL at 30 days demonstrated superiority over PTA in the primary endpoint analysis, defined as procedural success with a residual stenosis less than or equal to 30 percent without flow-limiting dissection, prior to drug-coated balloon (DCB) or stent, with a rate of 65.8 percent versus 50.4 percent (p=0.0065) as determined by an independent angiographic ...
R-One is a medical robot specifically designed to perform coronary angioplasties (stent implantation). From the comfort of a control station shielded against radiation, the physician uses joysticks to remotely control the devices needed for the procedure, such as guidewires, balloons and stents. ...
ByRobocath
Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard risk for adverse events from carotid endarterectomy (CEA). Previously, the stent was approved for use only in patients with anatomic or physiological criteria that put them at high risk of complications from more invasive surgical procedures. ...
The therapy is designed to open vessels and maintain patency without the use of permanent implants for the treatment of peripheral artery disease (PAD) of the lower extremities. ...
Intersect ENT’s PROPEL sinus implants uniquely provide mechanical stenting of a patient’s sinuses while providing localized delivery of the corticosteroid mometasone furoate directly to healing sinus tissue, features that have been shown previously to improve outcomes after sinus surgery.1-3 “As one of the first observational studies to use ...
Confluent supports the design, development and manufacturing of life-saving implants, minimally invasive delivery systems and other medical devices utilized in some of the most innovative and technologically challenging applications in the medical device industry. ...
Second Heart Assist, Inc: Second Heart Assist, Inc. has developed both a catheter-based circulatory assist pump and a wireless power chronic implant aortic stent pump to aid patients with heart failure and reverse cardio-renal dysfunction. ...
Another benefit of the PROPEL Contour implant is that it does not need to be removed and will dissolve after approximately 4-6 ...
(Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS. The first patients, who were under the care of ...
Nearly 20,000 patients were included (14,979 CEA and 4,993 TCAR) from the VQI CEA and carotid artery stent (CAS) registries over a 4-year time period (August 2016 to August 2020). ...